Table 3 Lipid elements significantly elevated and declined in pneumoconiosis patients compared with healthy control among the top 50 lipid elements defined on VIP scores (P-values)
From: Novel lipidomes profile and clinical phenotype identified in pneumoconiosis patients
Elevated > 1.5 fold | Declined < 2/threefold | ||||
|---|---|---|---|---|---|
Lipids | Fold | P-value | Lipids | Fold | P-value |
PE(16:0/16:1) | 2.68 | 0.00 | LPC(20:0) | 0.66 | 0.00 |
PE(18:1/18:3) | 2.65 | 0.00 | LPC(18:0) | 0.63 | 0.00 |
FFA(22:4) | 2.43 | 0.00 | PC(14:0/22:6) | 0.61 | 0.00 |
PE(18:1/18:2) | 2.19 | 0.00 | LPC(22:6) | 0.61 | 0.00 |
PE(18:1/18:1) | 2.07 | 0.00 | PE(14:0/20:4) | 0.61 | 0.00 |
PE(16:0/18:3) | 2.03 | 0.00 | PC(18:2/20:5) | 0.57 | 0.00 |
PE(18:2/18:2) | 2.02 | 0.00 | CER(24:1) | 0.56 | 0.00 |
PE(16:0/18:2) | 1.90 | 0.00 | PC(20:0/22:6) | 0.54 | 0.00 |
PE(16:0/18:1) | 1.82 | 0.01 | LPC(14:0) | 0.54 | 0.00 |
PE(18:2/20:2) | 1.79 | 0.01 | HCER(24:1) | 0.49 | 0.00 |
PE(P-18:0/22:4) | 1.63 | 0.00 | LPC(20:5) | 0.46 | 0.00 |
PE(16:0/16:1) | 1.61 | 0.01 | HCER(20:1) | 0.45 | 0.00 |
PE(18:0/16:0) | 1.60 | 0.00 | PE(P-18:0/20:5) | 0.44 | 0.00 |
PE(18:1/20:4) | 1.55 | 0.00 | PE(O-16:0/20:5) | 0.39 | 0.00 |
PE(18:1/20:3) | 1.51 | 0.01 | DCER(22:0) | 0.36 | 0.00 |
| Â | Â | Â | PC(20:0/20:5) | 0.34 | 0.00 |
| Â | Â | Â | CER(22:1) | 0.33 | 0.00 |
| Â | Â | Â | HCER(22:1) | 0.32 | 0.00 |